ROIV · Roivant Sciences Ltd. · Debt
$35.30
+0.60 (+1.73%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$25.06B
Shares
722.32M
Volume · Oct 20
1.12M
Avg daily vol (3M)
7.1M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 12,384,000 | 10-Q filed 2026-08-06 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 94,768,000 | 10-Q filed 2026-08-06 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1635088
CUSIP
G76279101
13F (30d)
61 filings
58 filers
Visit website
Investor relations